{
    "Trade/Device Name(s)": [
        "AtheNA Multi-Lyte HSV 1 & 2 IgG Test System",
        "AtheNA Multi-Lyte HSV 1 & 2 Test System",
        "AtheNA Multi-Lyte HSV 1 & 2 kit"
    ],
    "Submitter Information": "Zeus Scientific, Inc.",
    "510(k) Number": "K072178",
    "Predicate Device Reference 510(k) Number(s)": [
        "K000238"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXJ",
        "MYF"
    ],
    "Summary Letter Date": "May 23, 2008",
    "Summary Letter Received Date": "May 28, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3305"
    ],
    "Regulation Name(s)": [
        "Herpes Simplex Virus Serological Reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "serology",
        "immunology"
    ],
    "Analyte(s)": [
        "IgG antibodies to HSV-1",
        "IgG antibodies to HSV-2"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "Luminex instrument",
        "AtheNA Multi-Lyte instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Microparticle immunoassay",
        "Multiplexed immunoassay"
    ],
    "Methodologies": [
        "Immunoassay",
        "Multiplexed bead-based detection"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Kit",
        "System",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for AtheNA Multi-Lyte HSV 1 & 2 IgG Test System using multiplexed microparticle immunoassay for qualitative detection of HSV-1 and HSV-2 IgG antibodies in human serum",
    "Indications for Use Summary": "Intended for qualitative detection of IgG class antibodies to Herpes Simplex Virus 1 and 2 in human sera from sexually active adults and expectant mothers to aid in presumptive diagnosis of HSV-1 and HSV-2 infection; not intended for donor screening or self testing",
    "fda_folder": "Microbiology"
}